Latest News
AstraZeneca acquires biotechnology company Omniose to strengthen vaccine capabilities
10 November 2026 - Preclinical biotechnology company Omniose announced on Tuesday that it has been acquired by biopharmaceutical company AstraZeneca plc (STO:AZN) (LON:AZN) (NYSE:AZN).This acquisition brings Omniose's proprietary bioconjugation ...
Medivir secures US patent protection for fostrox and lenvatinib combination until 2044
10 November 2026 - Swedish pharmaceutical company Medivir AB (STO:MVIR) announced on Tuesday that it has secured a US patent covering the combination of fostroxacitabine bralpamide (fostrox) and lenvatinib for the treatment of hepatocellular carcinom...
Valneva reports 94% antibody persistence five years after single-dose chikungunya vaccination
10 November 2026 - French vaccine company Valneva SE (Nasdaq:VALN) (Euronext Paris:VLA) on Tuesday reported sustained antibody responses five years after a single dose of its chikungunya vaccine, IXCHIQ, with 94% of 221 evaluable participants maintai...
bioMérieux secures FDA clearance and IVDR CE marking for VITEK PRO diagnostic platform
10 November 2026 - French diagnostics company bioMérieux (Euronext Paris:BIM) announced on Tuesday that it has received US Food and Drug Administration (FDA) 510(k) clearance and European IVDR CE marking for VITEK PRO, its new automated microb...
PharmaLogic to acquire CDMO business and manufacturing facility from Lantheus
10 November 2026 - PharmaLogic Holdings Corp, an independent contract development and manufacturing organisation (CDMO) specialising in radiopharmaceuticals, announced on Monday a definitive agreement to acquire the CDMO business and Springfield, New...